Logo image of JBTM

JBT MAREL CORP (JBTM) Stock Fundamental Analysis

NYSE:JBTM - New York Stock Exchange, Inc. - US4778391049 - Common Stock - Currency: USD

133.25  -0.88 (-0.66%)

After market: 133.25 0 (0%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to JBTM. JBTM was compared to 128 industry peers in the Machinery industry. JBTM has a medium profitability rating, but doesn't score so well on its financial health evaluation. JBTM is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year JBTM was profitable.
In the past year JBTM had a positive cash flow from operations.
Each year in the past 5 years JBTM has been profitable.
Each year in the past 5 years JBTM had a positive operating cash flow.
JBTM Yearly Net Income VS EBIT VS OCF VS FCFJBTM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M 500M

1.2 Ratios

JBTM's Return On Assets of -1.38% is on the low side compared to the rest of the industry. JBTM is outperformed by 71.88% of its industry peers.
With a Return On Equity value of -2.69%, JBTM is not doing good in the industry: 69.53% of the companies in the same industry are doing better.
The Return On Invested Capital of JBTM (0.85%) is worse than 73.44% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for JBTM is significantly below the industry average of 10.69%.
The last Return On Invested Capital (0.85%) for JBTM is well below the 3 year average (5.49%), which needs to be investigated, but indicates that JBTM had better years and this may not be a problem.
Industry RankSector Rank
ROA -1.38%
ROE -2.69%
ROIC 0.85%
ROA(3y)9.73%
ROA(5y)8.16%
ROE(3y)19.95%
ROE(5y)18.56%
ROIC(3y)5.49%
ROIC(5y)6.97%
JBTM Yearly ROA, ROE, ROICJBTM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

1.3 Margins

In the last couple of years the Profit Margin of JBTM has declined.
JBTM has a worse Operating Margin (3.07%) than 67.19% of its industry peers.
In the last couple of years the Operating Margin of JBTM has declined.
Looking at the Gross Margin, with a value of 35.76%, JBTM is in the better half of the industry, outperforming 64.84% of the companies in the same industry.
In the last couple of years the Gross Margin of JBTM has grown nicely.
Industry RankSector Rank
OM 3.07%
PM (TTM) N/A
GM 35.76%
OM growth 3Y-9.42%
OM growth 5Y-7.55%
PM growth 3Y-16.35%
PM growth 5Y-5.58%
GM growth 3Y1.99%
GM growth 5Y3.46%
JBTM Yearly Profit, Operating, Gross MarginsJBTM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1

2. Health

2.1 Basic Checks

JBTM has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
JBTM has about the same amout of shares outstanding than it did 1 year ago.
JBTM has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, JBTM has a worse debt to assets ratio.
JBTM Yearly Shares OutstandingJBTM Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
JBTM Yearly Total Debt VS Total AssetsJBTM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

JBTM has an Altman-Z score of 1.66. This is a bad value and indicates that JBTM is not financially healthy and even has some risk of bankruptcy.
JBTM has a worse Altman-Z score (1.66) than 73.44% of its industry peers.
The Debt to FCF ratio of JBTM is 9.45, which is on the high side as it means it would take JBTM, 9.45 years of fcf income to pay off all of its debts.
JBTM's Debt to FCF ratio of 9.45 is on the low side compared to the rest of the industry. JBTM is outperformed by 61.72% of its industry peers.
A Debt/Equity ratio of 0.48 indicates that JBTM is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.48, JBTM is in line with its industry, outperforming 46.88% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.48
Debt/FCF 9.45
Altman-Z 1.66
ROIC/WACC0.09
WACC9.39%
JBTM Yearly LT Debt VS Equity VS FCFJBTM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

JBTM has a Current Ratio of 1.26. This is a normal value and indicates that JBTM is financially healthy and should not expect problems in meeting its short term obligations.
JBTM's Current ratio of 1.26 is on the low side compared to the rest of the industry. JBTM is outperformed by 84.38% of its industry peers.
JBTM has a Quick Ratio of 1.26. This is a bad value and indicates that JBTM is not financially healthy enough and could expect problems in meeting its short term obligations.
JBTM's Quick ratio of 0.74 is on the low side compared to the rest of the industry. JBTM is outperformed by 81.25% of its industry peers.
Industry RankSector Rank
Current Ratio 1.26
Quick Ratio 0.74
JBTM Yearly Current Assets VS Current LiabilitesJBTM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 20.55% over the past year.
Measured over the past 5 years, JBTM shows a small growth in Earnings Per Share. The EPS has been growing by 0.52% on average per year.
Looking at the last year, JBTM shows a very strong growth in Revenue. The Revenue has grown by 30.55%.
Measured over the past years, JBTM shows a decrease in Revenue. The Revenue has been decreasing by -2.48% on average per year.
EPS 1Y (TTM)20.55%
EPS 3Y8.17%
EPS 5Y0.52%
EPS Q2Q%14.12%
Revenue 1Y (TTM)30.55%
Revenue growth 3Y7%
Revenue growth 5Y-2.48%
Sales Q2Q%117.72%

3.2 Future

The Earnings Per Share is expected to grow by 19.26% on average over the next years. This is quite good.
JBTM is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.83% yearly.
EPS Next Y12.63%
EPS Next 2Y19.62%
EPS Next 3Y19.26%
EPS Next 5YN/A
Revenue Next Year109.09%
Revenue Next 2Y47.73%
Revenue Next 3Y20.22%
Revenue Next 5Y4.83%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
JBTM Yearly Revenue VS EstimatesJBTM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B
JBTM Yearly EPS VS EstimatesJBTM Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6 8

2

4. Valuation

4.1 Price/Earnings Ratio

JBTM is valuated quite expensively with a Price/Earnings ratio of 25.53.
Compared to the rest of the industry, the Price/Earnings ratio of JBTM is on the same level as its industry peers.
When comparing the Price/Earnings ratio of JBTM to the average of the S&P500 Index (27.30), we can say JBTM is valued inline with the index average.
JBTM is valuated rather expensively with a Price/Forward Earnings ratio of 18.26.
Based on the Price/Forward Earnings ratio, JBTM is valued a bit cheaper than the industry average as 63.28% of the companies are valued more expensively.
JBTM is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 21.76, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 25.53
Fwd PE 18.26
JBTM Price Earnings VS Forward Price EarningsJBTM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, JBTM is valued a bit more expensive than 75.78% of the companies in the same industry.
JBTM's Price/Free Cash Flow ratio is a bit more expensive when compared to the industry. JBTM is more expensive than 60.94% of the companies in the same industry.
Industry RankSector Rank
P/FCF 32.91
EV/EBITDA 45.38
JBTM Per share dataJBTM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 60

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
A more expensive valuation may be justified as JBTM's earnings are expected to grow with 19.26% in the coming years.
PEG (NY)2.02
PEG (5Y)49.3
EPS Next 2Y19.62%
EPS Next 3Y19.26%

3

5. Dividend

5.1 Amount

With a yearly dividend of 0.32%, JBTM is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 1.81, JBTM has a dividend in line with its industry peers.
With a Dividend Yield of 0.32, JBTM pays less dividend than the S&P500 average, which is at 2.37.
Industry RankSector Rank
Dividend Yield 0.32%

5.2 History

The dividend of JBTM has a limited annual growth rate of 0.48%.
JBTM has been paying a dividend for over 5 years, so it has already some track record.
JBTM has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)0.48%
Div Incr Years0
Div Non Decr Years4
JBTM Yearly Dividends per shareJBTM Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 0 0 0 0 0

5.3 Sustainability

The earnings of JBTM are negative and hence is the payout ratio. JBTM will probably not be able to sustain this dividend level.
The dividend of JBTM is growing, but earnings are growing more, so the dividend growth is sustainable.
DP-13.77%
EPS Next 2Y19.62%
EPS Next 3Y19.26%
JBTM Yearly Income VS Free CF VS DividendJBTM Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M 500M

JBT MAREL CORP

NYSE:JBTM (7/11/2025, 8:26:07 PM)

After market: 133.25 0 (0%)

133.25

-0.88 (-0.66%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)05-05 2025-05-05/bmo
Earnings (Next)08-04 2025-08-04/amc
Inst Owners87.94%
Inst Owner ChangeN/A
Ins Owners0.7%
Ins Owner Change7.08%
Market Cap6.93B
Analysts76.67
Price Target127.7 (-4.17%)
Short Float %3.99%
Short Ratio4.22
Dividend
Industry RankSector Rank
Dividend Yield 0.32%
Yearly Dividend0.41
Dividend Growth(5Y)0.48%
DP-13.77%
Div Incr Years0
Div Non Decr Years4
Ex-Date05-27 2025-05-27 (0.1)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)2.74%
Min EPS beat(2)-8.58%
Max EPS beat(2)14.05%
EPS beat(4)2
Avg EPS beat(4)-1.79%
Min EPS beat(4)-17.32%
Max EPS beat(4)14.05%
EPS beat(8)5
Avg EPS beat(8)0.37%
EPS beat(12)8
Avg EPS beat(12)2.53%
EPS beat(16)10
Avg EPS beat(16)4.03%
Revenue beat(2)1
Avg Revenue beat(2)-3.06%
Min Revenue beat(2)-6.26%
Max Revenue beat(2)0.14%
Revenue beat(4)2
Avg Revenue beat(4)-3.59%
Min Revenue beat(4)-8.83%
Max Revenue beat(4)0.61%
Revenue beat(8)2
Avg Revenue beat(8)-4.34%
Revenue beat(12)2
Avg Revenue beat(12)-5.74%
Revenue beat(16)4
Avg Revenue beat(16)-4.55%
PT rev (1m)-7.37%
PT rev (3m)-10.14%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-0.16%
EPS NY rev (1m)-0.44%
EPS NY rev (3m)-2.8%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.33%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.95%
Valuation
Industry RankSector Rank
PE 25.53
Fwd PE 18.26
P/S 3.18
P/FCF 32.91
P/OCF 26.86
P/B 1.69
P/tB N/A
EV/EBITDA 45.38
EPS(TTM)5.22
EY3.92%
EPS(NY)7.3
Fwd EY5.48%
FCF(TTM)4.05
FCFY3.04%
OCF(TTM)4.96
OCFY3.72%
SpS41.9
BVpS79.03
TBVpS-25.95
PEG (NY)2.02
PEG (5Y)49.3
Profitability
Industry RankSector Rank
ROA -1.38%
ROE -2.69%
ROCE 0.98%
ROIC 0.85%
ROICexc 0.86%
ROICexgc 4.52%
OM 3.07%
PM (TTM) N/A
GM 35.76%
FCFM 9.66%
ROA(3y)9.73%
ROA(5y)8.16%
ROE(3y)19.95%
ROE(5y)18.56%
ROIC(3y)5.49%
ROIC(5y)6.97%
ROICexc(3y)7.1%
ROICexc(5y)8.09%
ROICexgc(3y)24.27%
ROICexgc(5y)25.88%
ROCE(3y)6.33%
ROCE(5y)8.04%
ROICexcg growth 3Y-1.29%
ROICexcg growth 5Y-6.67%
ROICexc growth 3Y-5.85%
ROICexc growth 5Y-12.74%
OM growth 3Y-9.42%
OM growth 5Y-7.55%
PM growth 3Y-16.35%
PM growth 5Y-5.58%
GM growth 3Y1.99%
GM growth 5Y3.46%
F-Score3
Asset Turnover0.27
Health
Industry RankSector Rank
Debt/Equity 0.48
Debt/FCF 9.45
Debt/EBITDA 10.21
Cap/Depr 37.06%
Cap/Sales 2.18%
Interest Coverage 250
Cash Conversion 132.41%
Profit Quality N/A
Current Ratio 1.26
Quick Ratio 0.74
Altman-Z 1.66
F-Score3
WACC9.39%
ROIC/WACC0.09
Cap/Depr(3y)71.26%
Cap/Depr(5y)66.65%
Cap/Sales(3y)3.61%
Cap/Sales(5y)3.3%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)20.55%
EPS 3Y8.17%
EPS 5Y0.52%
EPS Q2Q%14.12%
EPS Next Y12.63%
EPS Next 2Y19.62%
EPS Next 3Y19.26%
EPS Next 5YN/A
Revenue 1Y (TTM)30.55%
Revenue growth 3Y7%
Revenue growth 5Y-2.48%
Sales Q2Q%117.72%
Revenue Next Year109.09%
Revenue Next 2Y47.73%
Revenue Next 3Y20.22%
Revenue Next 5Y4.83%
EBIT growth 1Y-62.47%
EBIT growth 3Y-3.08%
EBIT growth 5Y-9.84%
EBIT Next Year182.88%
EBIT Next 3Y48.03%
EBIT Next 5YN/A
FCF growth 1Y357.39%
FCF growth 3Y4%
FCF growth 5Y22.04%
OCF growth 1Y106.57%
OCF growth 3Y1.15%
OCF growth 5Y16.21%